FDA Accepts TREANDA(R) New Drug Application For The Treatment Of Relapsed Indolent Non-Hodgkin's Lymphoma (Medical News Today)
Cephalon, Inc. (Nasdaq: CEPH) announced that the U.S. Food and Drug Administration (FDA) has accepted the company's new drug application (NDA) for TREANDA(R) (bendamustine HCl) for Injection for the treatment of patients with indolent B-cell non-Hodgkin's lymphoma (NHL) who have progressed during or following treatment with rituximab or a rituximab-containing regimen.

Textronics, Inc. Receives FDA Clearance On Textile Electrode (Medical News Today)
Textronics, Inc. has received U.S. Food and Drug Administration (FDA) clearance to market its textile-based ECG Electrode for use in general electrocardiograph monitoring and recording procedures. The company's heart-sensing fabric offers a comfortable alternative to adhesive electrodes and metal wristbands that are commonly used with most ECG instruments on the market.